News
-
-
PRESS RELEASE
Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice
Drägerwerk AG & Co. KGaA completes share buyback program for 77,316 preferred shares as part of employee stock program, in compliance with Regulation (EU) No 596/2014 -
-
PRESS RELEASE
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2024: Net sales just below and earnings just above expectations – Forecast 2025
Drägerwerk AG & Co. KGaA reports preliminary figures for 2024, with net sales just below and earnings just above expectations. Forecast for 2025 includes growth in net sales and EBIT margin -
-
PRESS RELEASE
Drägerwerk AG & Co. KGaA: Changes in the chair of the Dräger Supervisory Board
Stefan Lauer to step down as Chairman of Dräger Supervisory Board due to health reasons. Maria Dietz to take over from January 1, 2025. Thorsten Grenz to chair other committees. Stefan Lauer to remain Chairman of Drägerwerk Verwaltungs AG -
-
PRESS RELEASE
Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
Drägerwerk AG & Co. KGaA extends share buyback for employee stock program until March 2025, acquiring 27,977 preferred shares by Nov 21, 2024 -
-
PRESS RELEASE
Drägerwerk AG & Co. KGaA: Dräger with good demand, robust net sales development and higher earnings in the first nine months of 2024
Drägerwerk AG & Co. KGaA reports good demand, robust net sales, and higher earnings in the first nine months of 2024, with order intake exceeding prior year and annual forecast confirmed
